Dr. Anna Y Vigil MD

Recommended Articles

• Botox May Be a Treatment Option for Migraines

  The National Institute for Health and Clinical Excellence (NICE), has prepared the draft guidance recommending the use of Botox or botulinum toxin type A in the treatment of migraine. According to this guidance, the injections should be stopped if the person has episodic migraine or if the...

• 8-Year-Old Boy with Muscular Dystrophy Shares His Touching Bucket List

  At just two-years-old, William Magee was diagnosed with Duchenne muscular dystrophy. Now 8 years old, and in the United Kingdom, William has already become an inspiration to many.In a recent article published on the Mirror, his mother discusses his severe progression of the disease and how William...

• Do Mood and Anxiety Affect Multiple Sclerosis Disability?

  In MS, the immune system attacks the myelin, which is the protective coating that encompasses the nerves of the central nervous system (CNS). This, in turn, leads to the formation of lesions or scars. Depending on what part of the CNS is involved – the brain, spinal cord, and/or optic nerves – a...

• NFL Player Clay Matthews Raises Money for Muscular Dystrophy with Special Cleats

  Football is for some a way of life, but for many die-hard fans, playing the sport itself is just a dream.  This is especially true for kids diagnosed with life-altering illnesses such as Duchenne muscular dystrophy (DMD).While playing the sport may not be a possibility for these kids, the...

• Opening Up About A Parkinson’s Diagnosis

  Being diagnosed with Parkinson’s can be a huge life-changer for anyone. Unfortunately, it is a progressive disease, so even with the help of surgery and medication, some parts of it will remain as part of your life. It can be possible, especially during the early stages of the disease, to live...

• Targeting Enzyme May Be an Approach to Alzheimer’s Therapy

  Targeting particular enzymes to cure diseases or to relieve symptoms has never been an easy task. Indiscriminate targeting often results in unnecessary potentially toxic effects. For the same reasons, early attempts to target HDAC2 were not successful.Researchers knew that HDAC2 plays a vital role...